Investment manager of International Biotech trust gives termination notice

SV Health to exit by February 2024

Valeria Martinez
clock • 3 min read

SV Health Managers, the fund manager and AIFM of the International Biotechnology (IBT) trust, will be terminating its investment management agreement in a year’s time to focus on its core healthcare venture business.

Unless agreed otherwise, the termination will take effect on 9 February 2024, although it could happen earlier if IBT finds a suitable alternative. The board has instructed advisers to review the fund's options to ensure continuity.  While this process continues, there will be no change to the management setup. Lead portfolio managers Ailsa Craig and Marek Poszepczynski have expressed their willingness to continue as joint lead managers "in a different capacity". Craig and Poszepczynski will continue to manage the quoted portfolio (90% of net assets) and Kate Bingham and Houman Ash...

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now


Already an Investment Week